Vaccine Collaboration: A New Era Against Enterovirus 71
A Historic Partnership for Vietnamese Healthcare
In a landmark event, Việt Nam Vaccine Joint Stock Company (VNVC) and Substipharm Biologics, a leading Swiss pharmaceutical company, signed a historic memorandum of cooperation. This collaboration focuses on boosting scientific and clinical research exchanges, improving professional knowledge for medical staff, and raising public awareness about disease prevention, with a particular emphasis on hand, foot, and mouth disease (HFMD) in children. The primary highlight of this partnership is the imminent arrival of a new vaccine aimed at combating HFMD, specifically targeting the Enterovirus 71 (EV71) strain.
Details of the New Vaccine
The new vaccine is highly recommended for children aged two months to six years. Clinical trials published in The Lancet confirmed the vaccine’s safety and effectiveness, indicating a protective efficacy of up to 96.8%. This high protective rate helps defend against the recent circulating EV71 subtype, ensuring long-term immunity. Hervé Profit, Senior Director at Substipharm Biologics, stated that this vaccine’s introduction will significantly enhance child health by minimizing the severe complications associated with EV71 infections.
Two months to six years is the recommendation.
No specific treatment for EV71.
This vaccines helps to minimize vulnerable.
For the next upcoming vaccine
| Age Group | Risk Level | Severity of Symptoms | Vaccine Recommendation |
|---|---|---|---|
| 2 months to 6 years | High | Moderate to Severe | Highly recommended |
| 7-13 Years | Moderate | Mild to Moderate | Recommended based on exposure |
| Adults 14-20 | Low | Mild to Rare | Advised if exposed in childcare settings |
The Burden of EV71
Hand, foot, and mouth disease, primarily caused by Coxsackie virus A16 (CA16) and EV71, poses a significant health threat, especially in Vietnamese kindergartens. While CA16 often manifests with mild symptoms, EV71 can lead to serious complications like encephalitis, meningitis, and even respiratory failure. The risk of severe illness due to the EV71 subtype is 16 times higher than other strains, making it crucial to implement preventative measures swiftly.
The risk of severe illness due to EV71 is 16 times higher than non-severe hand, foot, and mouth virus infections. It can lead to encephalitis, meningitis, myocarditis, pneumonia, pulmonary edema, respiratory failure, and circulatory failure. Not to mention circulation failure.
Preventative Measures & Awareness
It is important to note, families and caregivers should be vigilant in managing and caring for infected children, securing a guaranteed enough stock
A generated healthier kids. Ensure cleanliness at home and keep the children protected from the germs and other diseases.
Excellent cleanliness is brought to families
Prevent common-breath-Instrument avoid infection further
Real-Life Impact and Statistics
The collaboration between VNVC and Substipharm Biologics can potentially save thousands of Vietnamese children from severe HFMD complications each year. According to recent data, EV71 outbreaks have caused significant hospitalizations, particularly in kindergartens and childcare centers. By ensuring a sufficient and immediate supply of the new vaccine, both companies aim to drastically reduce the strain on the healthcare system and prevent tragic outcomes.
Pro Tip: Encourage parents and caregivers to educate themselves on the symptoms of EV71 and seek immediate medical attention if they suspect infection. Early intervention can significantly improve the recovery process.
Case Study: Success Stories
In countries where the EV71 vaccine has already been implemented, such as Singapore and Taiwan, significant reductions in HFMD-related hospitalizations and fatalities have been recorded. These success stories underscore the potential impact of widespread vaccination in Việt Nam.
FAQ
How does the new vaccine protect against EV71?
The new vaccine, effective for children 6 months to 12 years, confers a 96.8% protective effect against HFMD caused by EV71, ensuring long-term immunity.
to families by vaccinating the children
<!— Yes/No answer as specified —
What are the most common symptoms of EV71?
Initial symptoms include fever, poor appetite, irritability, and sore throat. These are followed by painful ulcers in the mouth and a rash with blisters on the hands and feet.
Comment on the article!
Do you have a story or opinion to share?
We’d love to hear from you. Please leave a comment or share this article with your friends on social media to help us spread awareness about the importance of HFMD prevention and vaccination.
